BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4975588)

  • 1. [The action of mescaline and lysergic acid diethylamide (LSD-25) on the behavior of the guinea pig].
    Sivadjian J
    C R Acad Hebd Seances Acad Sci D; 1969 Feb; 268(6):984-5. PubMed ID: 4975588
    [No Abstract]   [Full Text] [Related]  

  • 2. Congenital malformations induced by mescaline, lysergic acid diethylamide, and bromolysergic acid in the hamster.
    Geber WF
    Science; 1967 Oct; 158(3798):265-7. PubMed ID: 4861369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The preservation of substance P by lysergic acid diethylamide.
    KRIVOY WA
    Br J Pharmacol Chemother; 1957 Sep; 12(3):361-4. PubMed ID: 13460245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of cross-tolerance in rats among (-)delta9-trans-tetrahydrocannabinol(delta9-THC), cannabis extract, mescaline and lysergic acid diethylamide (LSD-25).
    Teresa M; Silva A; Carlini EA; Claussen U; Korte F
    Psychopharmacologia; 1968; 13(4):332-40. PubMed ID: 5722169
    [No Abstract]   [Full Text] [Related]  

  • 5. Lysergic acid diethylamide- and mescaline-induced attenuation of the effect of punishment in the rat.
    Schoenfeld RI
    Science; 1976 May; 192(4241):801-3. PubMed ID: 1063447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the hallucinogenic drugs LSD-25 and mescaline on the electroretinogram.
    APTER JT; PFEIFFER CC
    Ann N Y Acad Sci; 1957 Mar; 66(3):508-13; discussion, 513-4. PubMed ID: 13425239
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological and behavioral components of tolerance to LSD and mescaline in rats.
    Murray TF; Craigmill AL; Fischer GJ
    Pharmacol Biochem Behav; 1977 Sep; 7(3):239-44. PubMed ID: 928480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facilitation of avoidance behaviour by LSD-25 and mescaline in hamsters.
    Sansone M; Castellano C; Messeri P
    Pharmacol Res Commun; 1974 Aug; 6(4):369-76. PubMed ID: 4438404
    [No Abstract]   [Full Text] [Related]  

  • 9. The pharmacology of mescaline and D-lysergic acid diethylamide (LSD).
    KOELLE GB
    N Engl J Med; 1958 Jan; 258(1):25-32. PubMed ID: 13493730
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inhibition of development by psychotics].
    Kemper F
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):271-2. PubMed ID: 5817001
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychopharmacological studies of lysergic acid diethylamide (LSD-25) intoxication; effects of premedication with BOL-128 (2-bromo-d-lysergic acid diethylamide), mescaline, atropine, amobarbital, and chlorpromazine.
    CLARK LD; BLISS EL
    AMA Arch Neurol Psychiatry; 1957 Dec; 78(6):653-5. PubMed ID: 13478222
    [No Abstract]   [Full Text] [Related]  

  • 12. LSD and other related hallucinogens elicit myoclonic jumping behavior in the guinea pig.
    Carvey P; Nausieda P; Weertz R; Klawans H
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):199-210. PubMed ID: 2748860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cumulative alterations in rat behavior during continuous administration of LSD or mescaline: absence of tolerance?
    Ellison G; Ring M; Ross D; Axelrood B
    Biol Psychiatry; 1980 Feb; 15(1):95-102. PubMed ID: 7357060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance to a behavioral effect of lysergic acid diethylamide and cross-tolerance to mescaline in the rat: absence of a metabolic component.
    Winter JC
    J Pharmacol Exp Ther; 1971 Sep; 178(3):625-30. PubMed ID: 5571911
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of mescaline and lysergic acid diethylamide on flicker discrimination in the rat.
    Schechter MD; Winter JC
    J Pharmacol Exp Ther; 1971 May; 177(2):461-7. PubMed ID: 5568801
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological studies on para-bromo-methamphetamine (V-111) and LSD.
    Knoll J; Vizi ES; Knoll B
    Acta Physiol Acad Sci Hung; 1970; 37(1):151-70. PubMed ID: 5433553
    [No Abstract]   [Full Text] [Related]  

  • 17. Specificity of the antibody receptor site to D-lysergamide: model of a physiological receptor for lysergic acid diethylamide.
    Van Vunakis H; Farrow JT; Gjika HB; Levine L
    Proc Natl Acad Sci U S A; 1971 Jul; 68(7):1483-7. PubMed ID: 5283939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of mescaline and of lysergic acid diethylamide (LSD-25) on the development of primary and secondary conditioned avoidance reflexes in rats].
    MAFFII G
    Farmaco Sci; 1959 Jul; 14():503-15. PubMed ID: 13853753
    [No Abstract]   [Full Text] [Related]  

  • 19. Behavioural effects of some derivatives of amphetamine and LSD and their significance.
    Smythies JR; Beaton J; Benington F; Morin RD
    Nature; 1970 May; 226(5246):644-5. PubMed ID: 5444927
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolonged survival of the isolated retina induced by drugs; strychnine, mescaline, d-lysergic acid diethylamide (LSD), and atropine.
    APTER JT
    AMA Arch Ophthalmol; 1958 May; 59(5):722-30. PubMed ID: 13519998
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.